The study investigates a new treatment approach for patients with stage III melanoma that avoids traditional surgery, proposing to combine cryoablation with immunotherapy.
Fifteen patients underwent a specific treatment protocol that involved administering immunotherapy followed by cryoablation and further injections, all without any procedure failures reported.
Results indicate that this combination is feasible with manageable side effects, and over half of the patients showed significant positive responses to the treatment.